Acute Investment Advisory’s Bank of America BAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,104
Closed -$282K 18
2024
Q3
$282K Hold
7,104
0.16% 15
2024
Q2
$283K Hold
7,104
0.16% 14
2024
Q1
$269K Sell
7,104
-1,071
-13% -$36.8K 0.18% 9
2023
Q4
$275K Buy
8,175
+762
+10% +$22.2K 0.16% 13
2023
Q3
$203K Buy
+7,413
New +$219K 0.12% 13
2023
Q1
Sell
-7,498
Closed -$248K 14
2022
Q4
$248K Buy
+7,498
New +$258K 0.17% 18

Other funds holding BAC

Acute Investment Advisory's BAC Position: Q4 2024 in Review

Acute Investment Advisory sold out of Bank of America (BAC) in Q4 2024, closing a stake of 7,104 shares — an estimated $282K sold.

Acute Investment Advisory first reported a position in BAC in Q4 2022 and held it in 6 quarters. The position peaked at $283K in Q2 2024. 3,267 funds tracked by Wall St. Rank hold BAC as of Q4 2024.

  • Acute Investment Advisory reported no remaining Bank of America position as of Q4 2024 after selling out during the quarter.
  • Acute Investment Advisory sold 7,104 Bank of America shares in Q4 2024, an estimated $282K.
  • Acute Investment Advisory first reported a position in Bank of America in Q4 2022 and held it in 6 quarters.
  • Acute Investment Advisory's Bank of America position peaked at $283K in Q2 2024.
  • 3,267 funds tracked by Wall St. Rank held Bank of America as of Q4 2024.

Based on Acute Investment Advisory's 13F filing for Q4 2024, filed 24 Jan 2025.